3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
2
Status
Unknown
2
Withdrawn
1
Terminated
1
Recruiting
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
2
Sponsor
Cancer Type
Classical hematology
2
Genitourinary
1
Conditions
Febrile Neutropenia
2
Sepsis
1
Neoplasms
1
Fever
1
Emergencies
1
Interventions
avatrombopag
5
iron isomaltoside 1000
4
hetrombopag
3
ferric carboxymaltose
3
Cytarabine
3
eltrombopag
2
Rivaroxaban
2
Radiotherapy
2
Meropenem
2
Idarubicin
2
Granulocyte Colony-Stimulating Factor
2
Etoposide
2
Erythropoietin
2
Cyclophosphamide
2
Azacitidine
2
thymoglobulin
1
stinging nettle lectin
1
romiplostim
1
raltitrexed
1
peppermint oil
1
pegfilgrastim
1
oprelvekin
1
fludarabine phosphate
1
fludarabine
1
ferrous succinate
1
ferrous fumarate
1
ferric derisomaltose
1
epoetin beta
1
cc-486
1
Vitamin B 12
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Meropenem
×
Classical hematology
×
Clear all
NCT05393505
2022-12-06
FRANCiS-NF
The University of Hong Kong
Phase 4
Unknown
344 enrolled
NCT02463747
2015-06-04
RR
Tel-Aviv Sourasky Medical Center
Phase 4
Unknown
110 enrolled